Please login to the form below

Not currently logged in
Email:
Password:

Crescendo Biologics

This page shows the latest Crescendo Biologics news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress

Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress. ... Our highly productive relationship draws together Takeda’s deep oncology experience with Crescendo’s expertise in developing optimally configured

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    For example, in October, Takeda announced a cancer collaboration with Crescendo Biologics, which could be worth nearly $800m to the Cambridge-based biotech.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Crescendo Biologics appoints Edward Stewart as chief business officer Crescendo Biologics appoints Edward Stewart as chief business officer

    Crescendo Biologics appoints Edward Stewart as chief business officer. He joins the Cambridge, UK-based firm from Merrimack Pharmaceuticals. ... Biopharmaceutical group Crescendo Biologics has appointed Edward Stewart as its new chief business officer.

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    Cambridge, UK-based Crescendo Biologics has appointed Theodora Harold as its new chief financial officer. ... Dr Peter Pack, chief executive officer of Crescendo Biologics, said: “ Theo's appointment as Crescendo's new chief financial officer places us

  • C4X Discovery appoints chief executive officer C4X Discovery appoints chief executive officer

    Since joining GlaxoSmithKline's research department in 1988, Dix has held a series of senior leadership positions including chief executive officer of Convergence Pharmaceuticals and chairman of both Crescendo Biologics and

  • Crescendo Biologics appoints Dr Kevin Johnson as chairman Crescendo Biologics appoints Dr Kevin Johnson as chairman

    Crescendo Biologics appoints Dr Kevin Johnson as chairman. Brings Cambridge, UKfirm experience from Pangenetics. ... He said: “ Crescendo Biologics has a very promising pipeline in development based on its unique Humabodies platform. “

  • Crescendo Biologics appoints Peter Pack as CEO Crescendo Biologics appoints Peter Pack as CEO

    Crescendo Biologics appoints Peter Pack as CEO. Launches new strategy in oncology R&D. ... Crescendo Biologics has appointed Dr Peter Pack as CEO who will help to oversee the company's new strategy.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics